Farms.com Home   News

Broiler-Type Eggs Set in the United States Up 3 Percent

Broiler-Type Eggs Set in the United States Up 3 Percent

Hatcheries in the United States weekly program set 214 million eggs in incubators during the week ending February 7, 2015, up 3 percent from a year ago. Hatcheries in the 19 State weekly program set 206 million eggs in incubators during the week ending February 7, 2015, up 3 percent from the year earlier. Average hatchability for chicks hatched during the week in the United States was 83 percent. Average hatchability is calculated by dividing chicks hatched during the week by eggs set three weeks earlier. 

Broiler-Type Chicks Placed in the United States Up 3 Percent

Broiler growers in the United States weekly program placed 175 million chicks for meat production during the week ending February 7, 2015, up 3 percent from a year ago. Broiler growers in the 19 State weekly program placed 169 million chicks for meat production during the week ending February 7, 2015, up 3 percent from the year earlier. Cumulative placements from the week ending January 10, 2015 through February 7, 2015 for the United States were 876 million. Cumulative placements were up 3 percent from the same period a year earlier.

Source: USDA


Trending Video

New discovery may lead to better vaccines for pork producers

Video: New discovery may lead to better vaccines for pork producers



Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe disease in pigs, leading to significant economic losses for pork producers across the globe. It’s estimated that PRRS costs the Canadian pork industry $130M annually. Using the CMCF beamline, researchers from the University of Manitoba and the Leiden University Medical Centre (Netherlands) were able to see the structure of the PRRSV protease, a type of protein the pathogen uses to suppress a host’s immune system. The vital information they uncovered can be used to develop new vaccines against PRRSV and also helps inform development of vaccines against emerging human viruses.